Altimmune

ALTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$598.980 M

$3.08 +2.33%

Close of 7 Aug 2026

Revenue

$41.0K

#3631 by revenue

Earnings

-$88.1M

Loss-making

Shares outstanding

130,069,983

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#195Nuvectis PharmaNVCT$617.4M
#196ARS PharmaceuticalsSPRY$611.7M
#197AltimmuneALT$599.0M
#198VerastemVSTM$592.3M
#199CorMedixCRMD$583.7M

Where these numbers come from

Share counts and financials for Altimmune are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.